US Patent Issued to CAAMTECH on June 16 for "Quaternary tryptamines and their therapeutic uses" (Washington Inventor)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,655,102, issued on June 16, was assigned to CAAMTECH INC. (Issaquah, Wash.).

"Quaternary tryptamines and their therapeutic uses" was invented by Andrew R. Chadeayne (Issaquah, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to compounds of formula (I):Among the substituents in a compound of formula (I), one of R4 and R5 is hydrogen and the other of R4 and R5 is 13 OSO2R6. The disclosure relates to compounds of formula (II):Among the substituents in a compound of formula (II), R6 is a halogen chosen from F, Cl, Br, and I. The disclosure relates to compositions comprising a compound of formulas (I) or (II) and an excipient. The...